Podcast
MSL Talk: Tom Caravela, Giovanni Passiatore
3 Things I wish I knew about being a MSL
Summary
In this episode, Tom Caravela welcomes Mitchell D’Rozario from Genentech Roche to share his journey into the MSL role. Mitchell provides three key insights he wishes he had known before becoming an MSL and poses thought-provoking questions to Tom. The discussion covers staying motivated and purpose-driven, exploring alternative career paths in the pharmaceutical industry, and the challenges of building relationships in a virtual environment. They also delve into the changing landscape of conferences and the importance of face-to-face interactions. The episode concludes with closing remarks, gratitude, and a request for subscription and feedback.
My guest today is Mitchell D’Rozario, Medical Science Liaison at Genentech and we discuss the 3 things he wished he knew about being an MSL.
In this episode we discuss:
- Mitchell’s background and breaking into the industry
- 3 things he wishes he had known about being an MSL
- What Tom wishes aspiring MSLs knew about the role
- What Tom looks for when screening candidates for roles
- Some red flags Tom notices often
- What keeps Mitchell on track
- What Mitchell learned in 2020 going through pandemic and how it changed him as an MSL
- His opinion of what 2021 will look like for field medical and what MSLs might expect
MSL career insights, pharmaceutical industry careers, virtual relationship building, Medical Science Liaison challenges, conference networking importance
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Giovanni Passiatore
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO
Clinical Educator Oncology Program Improves Adherence by 29%
Article
Forbes Books Press Release Official